PlainRecalls
FDA Drug Moderate Class II Terminated

Zonisamide 100 mg Capsules, 30-count bottles, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-0775-30

Reported: September 29, 2021 Initiated: September 14, 2021 #D-0829-2021

Product Description

Zonisamide 100 mg Capsules, 30-count bottles, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-0775-30

Reason for Recall

CGMP deviations: Gaps in the quality system in the Quality Control microbiology laboratory.

Details

Recalling Firm
Direct Rx
Units Affected
2 bottles
Distribution
FL only
Location
Dawsonville, GA

Frequently Asked Questions

What product was recalled?
Zonisamide 100 mg Capsules, 30-count bottles, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-0775-30. Recalled by Direct Rx. Units affected: 2 bottles.
Why was this product recalled?
CGMP deviations: Gaps in the quality system in the Quality Control microbiology laboratory.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 29, 2021. Severity: Moderate. Recall number: D-0829-2021.